New Technologies in Cervical Cancer Screening
- 1 August 2008
- Vol. 26, K42-K52
- https://doi.org/10.1016/j.vaccine.2008.05.002
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical LesionsCancer Research, 2008
- Cost-Effectiveness Analyses of Vaccination ProgrammesPharmacoEconomics, 2008
- Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcriptsOncogene, 2007
- High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident diseaseInternational Journal of Cancer, 2007
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical CancerJournal of Clinical Microbiology, 2006
- Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical CarcinomasJournal of Clinical Microbiology, 2006
- Type‐specific associations of human papillomavirus load with risk of developing cervical carcinoma in situInternational Journal of Cancer, 2004
- Integrated Human Papillomavirus Type 16 Is Frequently Found in Cervical Cancer Precursors as Demonstrated by a Novel Quantitative Real-Time PCR TechniqueJournal of Clinical Microbiology, 2002